Ingo Stock

1.9k total citations
61 papers, 1.4k citations indexed

About

Ingo Stock is a scholar working on Molecular Medicine, Epidemiology and Endocrinology. According to data from OpenAlex, Ingo Stock has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Medicine, 15 papers in Epidemiology and 14 papers in Endocrinology. Recurrent topics in Ingo Stock's work include Antibiotic Resistance in Bacteria (21 papers), Enterobacteriaceae and Cronobacter Research (9 papers) and Yersinia bacterium, plague, ectoparasites research (7 papers). Ingo Stock is often cited by papers focused on Antibiotic Resistance in Bacteria (21 papers), Enterobacteriaceae and Cronobacter Research (9 papers) and Yersinia bacterium, plague, ectoparasites research (7 papers). Ingo Stock collaborates with scholars based in Germany, Switzerland and Sweden. Ingo Stock's co-authors include B. Wiedemann, Guido Funke, Robert F. Troxler, Alexander von Graevenitz, Peter Heisig, Motiur Rahman, Andrea Schiefer and Irith Wiegand and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Ingo Stock

58 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingo Stock Germany 21 465 461 312 298 207 61 1.4k
Maria Hoffmann United States 18 449 1.0× 577 1.3× 547 1.8× 436 1.5× 132 0.6× 44 1.6k
Frances W. Brenner United States 11 544 1.2× 410 0.9× 441 1.4× 820 2.8× 222 1.1× 11 1.8k
Dorthe Sandvang Denmark 24 550 1.2× 923 2.0× 420 1.3× 681 2.3× 108 0.5× 53 2.0k
Silpak Biswas China 19 279 0.6× 673 1.5× 331 1.1× 461 1.5× 82 0.4× 25 1.6k
Masaru Usui Japan 24 388 0.8× 829 1.8× 371 1.2× 371 1.2× 85 0.4× 126 1.8k
Juliana Pfrimer Falcão Brazil 22 370 0.8× 322 0.7× 388 1.2× 800 2.7× 246 1.2× 100 1.4k
Mustafa Simmons United States 14 364 0.8× 538 1.2× 516 1.7× 511 1.7× 129 0.6× 19 1.4k
Anne Mette Seyfarth Denmark 18 287 0.6× 702 1.5× 256 0.8× 437 1.5× 95 0.5× 20 1.5k
Aleisha Reimer Canada 17 416 0.9× 173 0.4× 353 1.1× 525 1.8× 259 1.3× 25 1.2k
Daniel A. Tadesse United States 14 489 1.1× 886 1.9× 581 1.9× 633 2.1× 158 0.8× 31 1.9k

Countries citing papers authored by Ingo Stock

Since Specialization
Citations

This map shows the geographic impact of Ingo Stock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Stock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Stock more than expected).

Fields of papers citing papers by Ingo Stock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Stock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Stock. The network helps show where Ingo Stock may publish in the future.

Co-authorship network of co-authors of Ingo Stock

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Stock. A scholar is included among the top collaborators of Ingo Stock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Stock. Ingo Stock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stock, Ingo. (2017). Syphilis – an update.. PubMed. 40(3). 113–9. 2 indexed citations
2.
Stock, Ingo. (2015). [Fosfomycin--its significance for treatment of diseases due to multidrug-resistant bacteria].. PubMed. 38(1). 4–11. 2 indexed citations
3.
Stock, Ingo, et al.. (2012). [Infections with Chlamydia trachomatis].. PubMed. 35(6). 209–22; quiz 223. 6 indexed citations
4.
5.
Schiefer, Andrea, et al.. (2005). Biochemical and genetic characterization of the β-lactamases of Y. aldovae, Y. bercovieri, Y. frederiksenii and ‘Y. ruckeri’ strains. International Journal of Antimicrobial Agents. 25(6). 496–500. 12 indexed citations
6.
Stock, Ingo, et al.. (2004). Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains. Clinical Microbiology and Infection. 10(8). 724–733. 65 indexed citations
7.
Stock, Ingo, et al.. (2004). Antimicrobial susceptibility patterns, β-lactamases, and biochemical identification of Yokenella regensburgei strains. Diagnostic Microbiology and Infectious Disease. 48(1). 5–15. 26 indexed citations
8.
Stock, Ingo, et al.. (2003). Moellerella wisconsensis: identification, natural antibiotic susceptibility and its dependency on the medium applied. Diagnostic Microbiology and Infectious Disease. 45(1). 1–11. 20 indexed citations
9.
Stock, Ingo, et al.. (2003). Natural Antibiotic Susceptibility ofEwingella americanaStrains. Journal of Chemotherapy. 15(5). 428–441. 8 indexed citations
10.
Stock, Ingo. (2003). Natural Antibiotic Susceptibility ofProteusspp., with Special Reference to P.mirabilisand P.penneriStrains. Journal of Chemotherapy. 15(1). 12–26. 59 indexed citations
11.
Stock, Ingo. (2003). Natural antimicrobial susceptibilities of strains of 'unusual' Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea. Journal of Antimicrobial Chemotherapy. 51(4). 865–885. 84 indexed citations
12.
Stock, Ingo, et al.. (2003). Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii. International Journal of Antimicrobial Agents. 22(1). 35–47. 101 indexed citations
13.
Stock, Ingo & B. Wiedemann. (2003). Natural antimicrobial susceptibilities and biochemical profiles ofYersinia enterocolitica-like strains:Y. frederiksenii,Y. intermedia,Y. kristenseniiandY. rohdei. FEMS Immunology & Medical Microbiology. 38(2). 139–152. 13 indexed citations
14.
Stock, Ingo & B. Wiedemann. (2002). Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains. Clinical Microbiology and Infection. 8(9). 564–578. 79 indexed citations
15.
16.
Stock, Ingo, et al.. (2001). Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. International Journal of Antimicrobial Agents. 18(6). 537–545. 40 indexed citations
17.
Troxler, Robert F., Guido Funke, Alexander von Graevenitz, & Ingo Stock. (2001). Natural Antibiotic Susceptibility of Recently Established Coryneform Bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 20(5). 315–323. 24 indexed citations
18.
Troxler, Robert F., Alexander von Graevenitz, Guido Funke, B. Wiedemann, & Ingo Stock. (2000). Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clinical Microbiology and Infection. 6(10). 525–535. 164 indexed citations
19.
Stock, Ingo & B. Wiedemann. (1999). Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains. Diagnostic Microbiology and Infectious Disease. 33(3). 187–199. 42 indexed citations
20.
Stock, Ingo & B. Wiedemann. (1998). Natural antibiotic susceptibility of Providencia stuartii, P. rettgeri, P. alcalifaciens and P. rustigianii strains. Journal of Medical Microbiology. 47(7). 629–642. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Hoffmann Breakdown of academic impact, for papers by Frances W. Brenner Breakdown of academic impact, for papers by Dorthe Sandvang Breakdown of academic impact, for papers by Silpak Biswas Breakdown of academic impact, for papers by Masaru Usui Breakdown of academic impact, for papers by Juliana Pfrimer Falcão Breakdown of academic impact, for papers by Mustafa Simmons Breakdown of academic impact, for papers by Anne Mette Seyfarth Breakdown of academic impact, for papers by Aleisha Reimer Breakdown of academic impact, for papers by Daniel A. Tadesse
Rankless by CCL
2026